These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21338093)

  • 1. Synthesis and characterization of PEGylated toll like receptor 7 ligands.
    Chan M; Hayashi T; Mathewson RD; Yao S; Gray C; Tawatao RI; Kalenian K; Zhang Y; Hayashi Y; Lao FS; Cottam HB; Carson DA
    Bioconjug Chem; 2011 Mar; 22(3):445-54. PubMed ID: 21338093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.
    Chan M; Hayashi T; Kuy CS; Gray CS; Wu CC; Corr M; Wrasidlo W; Cottam HB; Carson DA
    Bioconjug Chem; 2009 Jun; 20(6):1194-200. PubMed ID: 19445505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides.
    Shinchi H; Crain B; Yao S; Chan M; Zhang SS; Ahmadiiveli A; Suda Y; Hayashi T; Cottam HB; Carson DA
    Bioconjug Chem; 2015 Aug; 26(8):1713-23. PubMed ID: 26193334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
    Yu JE; Knight AK; Radigan L; Marron TU; Zhang L; Sanchez-Ramón S; Cunningham-Rundles C
    J Allergy Clin Immunol; 2009 Aug; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium.
    Asami T; Ishii M; Fujii H; Namkoong H; Tasaka S; Matsushita K; Ishii K; Yagi K; Fujiwara H; Funatsu Y; Hasegawa N; Betsuyaku T
    Mediators Inflamm; 2013; 2013():264260. PubMed ID: 24191131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
    Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
    J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold Nanoparticles Coimmobilized with Small Molecule Toll-Like Receptor 7 Ligand and α-Mannose as Adjuvants.
    Shinchi H; Yamaguchi T; Moroishi T; Yuki M; Wakao M; Cottam HB; Hayashi T; Carson DA; Suda Y
    Bioconjug Chem; 2019 Nov; 30(11):2811-2821. PubMed ID: 31560198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity.
    Huang CH; Mendez N; Echeagaray OH; Weeks J; Wang J; Vallez CN; Gude N; Trogler WC; Carson DA; Hayashi T; Kummel AC
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26637-26647. PubMed ID: 31276378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7.
    Hayashi T; Cottam HB; Chan M; Jin G; Tawatao RI; Crain B; Ronacher L; Messer K; Carson DA; Corr M
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R123-32. PubMed ID: 18480244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9.
    Kandimalla ER; Bhagat L; Wang D; Yu D; Sullivan T; La Monica N; Agrawal S
    Nucleic Acids Res; 2013 Apr; 41(6):3947-61. PubMed ID: 23396449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and immunostimulatory activity of sugar-conjugated TLR7 ligands.
    Baba A; Wakao M; Shinchi H; Chan M; Hayashi T; Yao S; Cottam HB; Carson DA; Suda Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126840. PubMed ID: 31864800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
    Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
    Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyco-Nanoadjuvants: Impact of Linker Length for Conjugating a Synthetic Small-Molecule TLR7 Ligand to Glyco-Nanoparticles on Immunostimulatory Effects.
    Shinchi H; Komaki F; Yuki M; Ohara H; Hayakawa N; Wakao M; Cottam HB; Hayashi T; Carson DA; Moroishi T; Suda Y
    ACS Chem Biol; 2022 Apr; 17(4):957-968. PubMed ID: 35353497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
    Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
    J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell-mediated inhibition of abdominal neutrophil inflammation by a PEGylated TLR7 ligand.
    Hayashi T; Yao S; Crain B; Chan M; Cottam HB; Lao F; Carson DA; Corr M
    Mediators Inflamm; 2012; 2012():262394. PubMed ID: 22619481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
    Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
    PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22.
    Wang Q; Kim SY; Matsushita H; Wang Z; Pandyarajan V; Matsuda M; Ohashi K; Tsuchiya T; Roh YS; Kiani C; Zhao Y; Chan M; Devkota S; Lu SC; Hayashi T; Carson DA; Seki E
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway.
    Hu Y; Cong X; Chen L; Qi J; Wu X; Zhou M; Yoo D; Li F; Sun W; Wu J; Zhao X; Chen Z; Yu J; Du Y; Wang J
    Sci Rep; 2016 Apr; 6():23977. PubMed ID: 27046485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.